StockDrifts LogoStockDrifts

Kainos Med 284620

Company
카이노스메드Kainos Med
Insiders
0
Buys
0
Total Value
—
Avg Return
—
Last Filing
2024-06-05

Kainos Med (284620) has 0 disclosed insider purchases and 0 disclosed disposals on record, filed by 0 distinct insiders. The earliest filing StockDrifts holds for Kainos Med is dated 2024-06-05; the most recent is 2024-06-05.

Price & insider activity (12 months)

Recent insider trades

DateTypeSourceInsiderPositionSharesPrice at filingReturnValue
2024-06-05SELL증여
이기섭
Lee Ki-seop
CEO-500.0K₩4,020+73.0%₩2.0B ($1.4M)

Frequently asked questions

Who has been buying Kainos Med stock?
0 distinct insiders have filed 0 disclosed insider purchases in Kainos Med (284620), most recently on 2024-06-05. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.
How many insider filings does Kainos Med have?
Kainos Med has 0 buy-side and 0 sell-side disclosures on record, spanning 2024-06-05 to 2024-06-05.
Do insider buys in Korean stocks predict returns?
Not uniformly. StockDrifts analysed 170,720 share-count changes across 56,930 Korean regulatory filings using cross-sectional alpha at fixed forward horizons, and found returns concentrated in particular signal tiers rather than in insider buying generally.

More on this data

Every trade listed above comes from an official regulatory disclosure. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.